PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Suh GH et al. – Alzheimer's drugs, albeit available, are often unaffordable for those who need them most. It is hoped that equitable differential pricing will be applied to Alzheimer's drugs.

   

Related Articles

Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09    Relevance Score: 71%

High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09    Relevance Score: 70%

Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09    Relevance Score: 69%

The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases
CNS Neuroscience & Therapeutics, 11/11/09    Relevance Score: 68%

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Neuropsychiatric Disease and Treatment, 11/04/09    Relevance Score: 68%

Today in Psychiatry...keeping you current

Anxious and depressive symptoms in Parkinson's disease: The French cross-sectionnal DoPaMiP study
Movement Disorders, 12/03/09

Meta-analyses: a method to maximise the evidence from clinical studies
European Archives of Psychiatry and Clinical Neuroscience, 12/03/09

Access to Medical Care, Use of Preventive Services, and Chronic Conditions Among Adults in Substance Abuse Treatment
Psychiatric Services, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address